Loading...

Isodiol International Inc.

ISOLF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.00
$0.00(0.00%)

Isodiol International Inc. (ISOLF) Stock Overview

Explore Isodiol International Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap491
P/E Ratio-0.00
EPS (TTM)$-0.39
ROE-4.27%

AI Price Forecasts

1 Week$0.00
1 Month$0.00
3 Months$0.01
1 Year Target$0.00

ISOLF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Isodiol International Inc. (ISOLF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.00 and a market capitalization of 491. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for ISOLFStats details for ISOLF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for ISOLFAnalyst Recommendations details for ISOLF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products. It is also involved in manufacturing and distributing hemp oil and nicotine e-liquids, as well as personal care products; provision of apparel and merchandising solutions; manufactures and sells hemp infused beverages; and supplies pharmaceutical products. The company is headquartered in Vancouver, Canada.

CEO

Marcos Agramont

Headquarters

200 Granville Street, Vancouver, BC

Founded

2014

Frequently Asked Questions

;